Dolca Thomas's most recent trade in Allakos Inc was a trade of 154,786 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Allakos Inc | Dolca Thomas | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 May 2025 | 154,786 | 0 | - | - | Stock Option (right to buy) | |
Allakos Inc | Dolca Thomas | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 May 2025 | 41,000 | 0 | - | - | Stock Option (right to buy) | |
Allakos Inc | Dolca Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 41,000 | 41,000 | - | - | Stock Option (Right to buy) | |
Allakos Inc | Dolca Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 154,786 | 154,786 | - | - | Stock Option (Right to buy) | |
Equillium Inc | Dolca Thomas | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 450,000 | 450,000 | - | - | Stock Option (right to buy) |